People in many countries used to like to go out for sightseeing and shopping, but due to the COVID-19 epidemic, people in these countries will choose to stay at home as much as possible. They won't go out unless they want to buy food or necessities, and they need to wear masks when they go out. Now all over the world. The total number of confirmed cases in COVID-19 has reached 654.38 billion. You know, on our planet, the total population of human beings living is only about 7 billion. This is a very large number.
Now, the COVID-19 epidemic is bothering us. The three worst countries are the United States, Brazil and India. The number of COVID-19 cases in the United States has reached more than 30 million, while the number of people who died of COVID-19's disease in the United States has reached more than 560,000. Although the fatality rate of COVID-19 epidemic is not as high as that of some other viruses, it is very severe. If the number of people infected is large, then the number of people who died from COVID-19 virus will not be small. Therefore, in order to curb the further development of the COVID-19 epidemic, countries with the ability have begun to develop vaccines. China is one of the most effective countries in developing vaccines.
1. COVID-19 vaccine developed by China;
There are five kinds of COVID-19 vaccines in China, and several of these five kinds of COVID-19 vaccines have been vaccinated in the population, and the feedback effect is also very good. Some COVID-19 vaccines have also been exported to other countries, which has helped to contain the COVID-19 epidemic in other countries. Of the five vaccines in our country, two are produced by Sinopharm. These two vaccines are inactivated vaccines, and one is produced by Beijing Zhongxing Kewei Company. This vaccine is also an inactivated virus vaccine. The other vaccine is an adenovirus vector vaccine produced by Kangxinuo Company. The above four vaccines are conditionally approved for marketing. In addition to these four vaccines, the other vaccine is a recombinant subunit vaccine produced by Zhifeilong Coma Company. This vaccine has been or has been approved for emergency use.
Second, China COVID-19 vaccine was certified by EU GMP for the first time. What's the impact on China?
The good news these two days is that the COVID-19 vaccine developed by China Sinopharm Group Beijing Research Institute has been approved by relevant Hungarian authorities. Subsequently, it was officially awarded COVID-19 Vaccine and EU GMP certificate. This has also become the first 1 GMP certified vaccine product in the history of China.
Speaking of it, GMP's EU certificate is very heavy because it is the gateway to the European market. Without this certificate, it can't be sold in EU countries. The certificate is mutually recognized among EU member states. You can also enjoy the inspection results of several other countries outside the EU. Therefore, the influence of this certificate on a global scale is also great, and its influence is still expanding.
China's vaccine obtained this certification, probably because when the vaccine was exported to Hungary, the Hungarian people thought that the vaccination effect was very good. It is worth mentioning that Hungary is the first EU country to use China vaccine.
Third, summary:
It is hoped that the vaccine produced in China will become the guarantee for more and more countries, and that the vaccine produced in China will provide more and more countries with an effective virus-free epidemic in COVID-19.